These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 15976038

  • 21. Pharmacological inhibition of the hERG potassium channel is modulated by extracellular but not intracellular acidosis.
    DU CY, El Harchi A, Zhang YH, Orchard CH, Hancox JC.
    J Cardiovasc Electrophysiol; 2011 Oct; 22(10):1163-70. PubMed ID: 21489024
    [Abstract] [Full Text] [Related]

  • 22. Investigating the utility of adult zebrafish ex vivo whole hearts to pharmacologically screen hERG channel activator compounds.
    Hull CM, Genge CE, Hobbs Y, Rayani K, Lin E, Gunawan M, Shafaattalab S, Tibbits GF, Claydon TW.
    Am J Physiol Regul Integr Comp Physiol; 2019 Dec 01; 317(6):R921-R931. PubMed ID: 31664867
    [Abstract] [Full Text] [Related]

  • 23. Clemastine, a conventional antihistamine, is a high potency inhibitor of the HERG K+ channel.
    Ridley JM, Milnes JT, Hancox JC, Witchel HJ.
    J Mol Cell Cardiol; 2006 Jan 01; 40(1):107-18. PubMed ID: 16288909
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. BeKm-1, a peptide inhibitor of human ether-a-go-go-related gene potassium currents, prolongs QTc intervals in isolated rabbit heart.
    Qu Y, Fang M, Gao B, Chui RW, Vargas HM.
    J Pharmacol Exp Ther; 2011 Apr 01; 337(1):2-8. PubMed ID: 21205913
    [Abstract] [Full Text] [Related]

  • 26. Altering extracellular potassium concentration does not modulate drug block of human ether-a-go-go-related gene (hERG) channels.
    Limberis JT, Su Z, Cox BF, Gintant GA, Martin RL.
    Clin Exp Pharmacol Physiol; 2006 Nov 01; 33(11):1059-65. PubMed ID: 17042915
    [Abstract] [Full Text] [Related]

  • 27. Investigating dynamic protocol-dependence of hERG potassium channel inhibition at 37 degrees C: Cisapride versus dofetilide.
    Milnes JT, Witchel HJ, Leaney JL, Leishman DJ, Hancox JC.
    J Pharmacol Toxicol Methods; 2010 Nov 01; 61(2):178-91. PubMed ID: 20172036
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action.
    Busch AE, Eigenberger B, Jurkiewicz NK, Salata JJ, Pica A, Suessbrich H, Lang F.
    Br J Pharmacol; 1998 Jan 01; 123(1):23-30. PubMed ID: 9484850
    [Abstract] [Full Text] [Related]

  • 30. Pharmacological removal of human ether-à-go-go-related gene potassium channel inactivation by 3-nitro-N-(4-phenoxyphenyl) benzamide (ICA-105574).
    Gerlach AC, Stoehr SJ, Castle NA.
    Mol Pharmacol; 2010 Jan 01; 77(1):58-68. PubMed ID: 19805508
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effects of the class III antiarrhythmic agent dofetilide (UK-68,798) on L-type calcium current from rabbit ventricular myocytes.
    Paul AA, Leishman DJ, Witchel HJ, Hancox JC.
    J Pharm Pharmacol; 2001 Dec 01; 53(12):1671-8. PubMed ID: 11804397
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. In vivo effects of the IKr agonist NS3623 on cardiac electrophysiology of the guinea pig.
    Hansen RS, Olesen SP, Rønn LC, Grunnet M.
    J Cardiovasc Pharmacol; 2008 Jul 01; 52(1):35-41. PubMed ID: 18594476
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.